Risk of admission to hospital for serious infection after initiating tofacitinib versus biologic DMARDs in patients with rheumatoid arthritis: a multidatabase cohort study
Ajinkya Pawar, Rishi Desai, Nileesa Gautam, Seoyoung C. Kim
Topics & Concepts
TofacitinibRheumatoid arthritisMedicineCohortInternal medicineRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsStreptococcal Infections and Treatments